MONITORING OF IMMUNOGLOBULIN LEVELS IN RA PATIENTS ON ANTI CD20, RITUXIMAB

被引：0
|
作者：
Rice, Ceara [1 ]
Ghandi-Das, Dhivya [1 ]
Negi, Anurag [1 ]
机构：
[1] Univ Hosp Wales, Rheumatol, Cardiff, Wales
来源：
RHEUMATOLOGY | 2020年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P202
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [21] Surface Levels of CD20 Determine Anti-CD20 Antibodies Mediated Cell Death In Vitro
    Singh, Vijay
    Gupta, Damodar
    Arora, Rajesh
    Tripathi, Rajendra Prashad
    Almasan, Alexandru
    Macklis, Roger M.
    PLOS ONE, 2014, 9 (11):
  • [22] Structural changes in the internal domain of CD20 antigen associated with the emergence of rituximab resistance: Effects of proteasome inhibition in CD20 structure and rituximab anti-tumor activity in rituximab-resistant cell lines (RRCL).
    Hernandez-Ilizaliturri, FJ
    Olejniczak, SH
    Knight, J
    Czuczman, MS
    BLOOD, 2005, 106 (11) : 425A - 425A
  • [23] Mutation of CD20 gene causes resistance to therapy with rituximab
    Terui, Y
    Sakurai, T
    Mishima, Y
    Mishima, Y
    Yokoyama, M
    Hatake, K
    ANNALS OF ONCOLOGY, 2005, 16 : 78 - 79
  • [24] The intensity of CD20 expression determines the outcome of rituximab treatment
    Novakovic, Barbara Jezersek
    Horvat, Mateja
    Prevodnik, Veronika Koboves
    Novakovic, Srdjan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2010, 26 : S11 - S11
  • [25] Structure of CD20 in complex with the therapeutic monoclonal antibody rituximab
    Rouge, Lionel
    Chiang, Nancy
    Steffek, Micah
    Kugel, Christine
    Croll, Tristan I.
    Tam, Christine
    Estevez, Alberto
    Arthur, Christopher P.
    Koth, Christopher M.
    Ciferri, Claudio
    Kraft, Edward
    Payandeh, Jian
    Nakamura, Gerald
    Koerber, James T.
    Rohou, Alexis
    SCIENCE, 2020, 367 (6483) : 1224 - +
  • [26] Reply to Rituximab activity in CD20 positive multiple myeloma
    A Gozzetti
    A Fabbri
    S Lazzi
    M Bocchia
    F Lauria
    Leukemia, 2007, 21 : 1842 - 1843
  • [27] The Alternative CD20 Transcript Variant Is Not a Factor for Resistance to Rituximab in Patients with Rheumatoid Arthritis
    Gamonet, Cecile
    Deschamps, Marina
    Marion, Sandrine
    Saas, Philippe
    Chioccha, Gilles
    Ferrand, Christophe
    Toussirot, Eric
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S440 - S440
  • [28] STRUCTURE OF CD20 BOUND TO RITUXIMAB REVEALS MECHANISTIC INFORMATION
    不详
    CANCER DISCOVERY, 2020, 10 (04) : 488 - 488
  • [29] Structural basis for recognition of CD20 by therapeutic antibody rituximab
    Du, Jiamu
    Wang, Hao
    Zhong, Chen
    Peng, Baozhen
    Zhang, Meilan
    Li, Bohua
    Huo, Sheng
    Guo, Yajun
    Ding, Jianping
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (20) : 15073 - 15080
  • [30] Reply to rituximab activity in CD20 positive multiple myeloma
    Gozzetti, A.
    Fabbri, A.
    Lazzi, S.
    Bocchia, M.
    Lauria, F.
    LEUKEMIA, 2007, 21 (08) : 1842 - 1843
12345